A clinical-stage biotechnology company developing precision medicines for kidney diseases

The world leader in development of ex vivo expanded universal donor cellular therapies, available on demand for treatment of life threatening diseases

A clinical stage biopharmaceutical company committed to the development and commercialization of novel medicines for the treatment of cancer, respiratory, and autoimmune diseases.

A privately-held biotechnology company developing innovative oral medicines to improve the health of patients with cancer or inflammatory diseases. Acquired by Gilead for $600 million ($375 million up-front and $225 million in contingent milestones) on April 1, 2011.Responsible for all aspects of the day-to-day finance and accounting operations of the Company including, payroll, accounts payable, cash and risk management, financial reporting, budgeting and forecasting, development of… Show more A privately-held biotechnology company developing innovative oral medicines to improve the health of patients with cancer or inflammatory diseases. Acquired by Gilead for $600 million ($375 million up-front and $225 million in contingent milestones) on April 1, 2011.Responsible for all aspects of the day-to-day finance and accounting operations of the Company including, payroll, accounts payable, cash and risk management, financial reporting, budgeting and forecasting, development of internal controls and procedures, preparation of Board and Audit Committee materials, and support of various strategic initiatives. Initial focus involved putting systems, processes, controls and staff in place to position the Company for a possible IPO. Supported due diligence process and worked in a three-month transition role with Gilead following the acquisition. Show less

Consulting for various companies on a project-specific basis. Projects include the development of various financial models to support financing opportunities; a goodwill valuation analysis; an SEC de-listing appeal; developing written processes, procedures and internal control documentation and setting up the accounting structure and financial systems for a start-up company;

A biotechnology company focused on the development of targeted molecular therapies. My position was eliminated at the end of 2008 as part of a downsizing to enable the Company to conserve cash. Managed staff of five accounting professionals responsible for all aspects of accounting and finance including: SEC and internal reporting; preparation of Board and Audit Committee materials; Sarbanes Oxley documentation, testing and compliance; risk management; budgeting and forecasting;… Show more A biotechnology company focused on the development of targeted molecular therapies. My position was eliminated at the end of 2008 as part of a downsizing to enable the Company to conserve cash. Managed staff of five accounting professionals responsible for all aspects of accounting and finance including: SEC and internal reporting; preparation of Board and Audit Committee materials; Sarbanes Oxley documentation, testing and compliance; risk management; budgeting and forecasting; financial analysis; project accounting and billing; accounts payable, payroll, purchasing, fixed assets and 401K and stock plan administration. Show less

Biopharmaceutical company with in excess of 700 employees, engaged in the discovery and development of product candidates for treatment of serious medical diseases. Developed and commercialized Cialis® with 2010 annual sales in excess of $1.7 billion. Acquired by Eli Lilly in January 2007 for $2.3 billion.Directed team of four Financial Analysts responsible for providing financial and accounting expertise and support to each functional area and project team within the company… Show more Biopharmaceutical company with in excess of 700 employees, engaged in the discovery and development of product candidates for treatment of serious medical diseases. Developed and commercialized Cialis® with 2010 annual sales in excess of $1.7 billion. Acquired by Eli Lilly in January 2007 for $2.3 billion.Directed team of four Financial Analysts responsible for providing financial and accounting expertise and support to each functional area and project team within the company, including researching and determining appropriate treatment of complex accounting transactions. Show less

Managed all accounting functions including: general ledger, accounts payable, fixed assets, cash management and payroll; financial reporting, budgeting and forecasting processes; and annual audit and quarterly reviews.

Key responsibilities included general ledger maintenance, cost accounting, fixed asset accounting, budgeting and forecasting, financial statement preparation and analysis, coordination of annual audit, and preparation of tax returns.